Haemophilus B Polysaccharide Conjugate (Tetanus Toxoid Conjugate) Vaccine
Item Name Code (INC) 49564
Additional Information for Haemophilus B Polysaccharide Conjugate (Tetanus Toxoid Conjugate) Vaccine
Haemophilus B Polysaccharide Conjugate (Tetanus Toxoid Conjugate) Vaccine is a type of vaccine that helps protect against Haemophilus influenzae type b (Hib) infection. It is classified under the supply class Drugs And Biologicals in the supply group Medical, Dental, And Veterinary Equipment And Supplies.
Hib infection can cause serious illnesses such as meningitis, pneumonia, and other invasive diseases, especially in young children. The vaccine works by stimulating the immune system to produce antibodies against the Hib bacteria, providing immunity against future infections.
The Haemophilus B Polysaccharide Conjugate (Tetanus Toxoid Conjugate) Vaccine is typically administered as a series of doses, starting in infancy. It is usually given in combination with other routine childhood vaccines.
It is important to consult with a healthcare professional or follow the recommended vaccination schedule provided by your local health authorities to ensure proper administration and protection against Hib infection.
Please note that this information is for general knowledge purposes only, and it is always best to consult with a healthcare professional for specific medical advice and guidance.